These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1287)

  • 1. Bufuralol, a new beta-adrenoceptor blocking agent.
    Fothergill GA; Francis RJ; Hamilton TC; Osbond JM; Parkes MW
    Experientia; 1975 Nov; 31(11):1322-3. PubMed ID: 1287
    [No Abstract]   [Full Text] [Related]  

  • 2. Bufuralol, a new beta-adrenoceptor blocking agent. Part 1: synthesis and structure-activity studies in a series of benzofuran-2-ethanolamines.
    Fothergill GA; Osbond JM; Wickens JC
    Arzneimittelforschung; 1977; 27(5):978-81. PubMed ID: 18158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of peripheral resistance after acute intravenous application of a new beta-receptor blocking agents, bufuralol HCl.
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G; Korn A
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):54-8. PubMed ID: 24595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.
    Hicks DC; Phillips EM
    Br J Pharmacol; 1972 Feb; 44(2):377P-378P. PubMed ID: 4148922
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol.
    Magometschnigg D; Bonelli J; Kaik G
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)].
    Rostan A
    Schweiz Rundsch Med Prax; 1978 Jan; 67(1):27-35. PubMed ID: 23523
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenoceptor activity of the stereoisomers of the bufuralol alcohol and ketone metabolites.
    Machin PJ; Hurst DN; Osbond JM
    J Med Chem; 1985 Nov; 28(11):1648-51. PubMed ID: 2866246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols.
    Large MS; Smith LH
    J Med Chem; 1980 Feb; 23(2):112-7. PubMed ID: 6102152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. -Adrenergic blocking agents. 11. Heterocyclic analogs of pronethalol (2-isopropylamino-1-(2-naphthyl)ethanol).
    Chodnekar MS; Crowther AF; Hepworth W; Howe R; McLoughlin BJ; Mitchell A; Rao BS; Slatcher RP; Smith LH; Stevens MA
    J Med Chem; 1972 Jan; 15(1):49-57. PubMed ID: 4399807
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol.
    Magometschnigg D; Bonelli J; Kaik G; Rameis H
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):334-40. PubMed ID: 39899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methoxyphenylethanolamines, potential beta-adrenergic blocking agents.
    Williams LR; Lap BV; Lim CH; Temple DM; Easson PA; Letts GL
    J Med Chem; 1978 Oct; 21(10):1081-4. PubMed ID: 31474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic receptor agonists. Benzofuranylethanolamines.
    Lövgren K; Hedberg A; Nilsson JL
    J Med Chem; 1980 Jun; 23(6):624-7. PubMed ID: 6104731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues.
    Hwang SK; Juhasz A; Yoon SH; Bodor N
    J Med Chem; 2000 Apr; 43(8):1525-32. PubMed ID: 10780909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.
    Blaber LC; Burden DT; Eigenmann R; Gerold M
    J Cardiovasc Pharmacol; 1984; 6(1):165-75. PubMed ID: 6199600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality].
    Balant L; Gorgia A; Tschopp JM; Revillard C; Fabre J
    Schweiz Med Wochenschr; 1976 Oct; 106(41):1403-7. PubMed ID: 12563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological properties of nebivolol, a new antihypertensive compound.
    Van Lommen G; De Bruyn M; Schroven M
    J Pharm Belg; 1990; 45(6):355-60. PubMed ID: 1982295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible beta-adrenoceptor blockade of atrial rate and tension responses.
    Nicholson CD; Broadley KJ
    Eur J Pharmacol; 1978 Dec; 52(3-4):259-69. PubMed ID: 32050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-(4-chloro-3-nitrophenyl)-beta-aminoethanols: potential beta-adrenergic blocking agents.
    Shafik RM; Soliman FS
    Pharmazie; 1976 Jul; 31(7):481-2. PubMed ID: 10579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preparation and beta adrenolytic activity of some derivatives of naphthol-[2,1-b]furan].
    Giovanninetti G; Garuti L; Chiarini A; Gaggi R
    Farmaco Sci; 1981 Feb; 36(2):94-101. PubMed ID: 6112160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.